Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 35
Selected: 0
NCT IDTitle
NCT02446444Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
NCT02889874EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer
NCT00193882Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
NCT05576831STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision
NCT05611931Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
NCT00659373Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02
NCT02662062Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
NCT00532194An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
NCT04789096Tucatinib Together with Pembrolizumab and Trastuzumab
NCT02773524A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer
NCT04918810Biomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT06358469STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision
NCT02948543Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer
NCT06728150Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer
NCT05150236EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC
NCT03057106Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
NCT01924819Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma
NCT06445738Post-operative Radiotherapy Omission in Selected Patients with Early Breast Cancer Trial International VErsion (PROSPECTIVE)
NCT00411138Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer
NCT02385214MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
NCT02273375Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
NCT02374242Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases
NCT02394132Radiotherapy or Imiquimod in Complex Lentigo Maligna
NCT00860652Radiotherapy - Adjuvant Versus Early Salvage
NCT03091764Evaluation of a Patient-Reported Symptom Index for NMIBC
NCT02947685Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
NCT03161756Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
NCT00189553Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse
NCT04343885In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy
NCT02401685POSNOC - A Trial Looking at Axillary Treatment in Early Breast Cancer
NCT02166788Evaluation of Groin Lymphadenectomy Extent For Metastatic Melanoma
NCT02392871Radiotherapy & Combi in Metastatic Melanoma
NCT01142011A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia
NCT03392428A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer
NCT04031677Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma